APA

Morschhauser F., Machiels J., Salles G., Rottey S., Rule S. A. J., Cunningham D., Peyrade F., Fruchart C., Arkenau H., Genvresse I., Liu L., Köchert K., Shen K., Kneip C., Peña C. E., Grevel J., Zhang J., Cisternas G., Reschke S., Granvil C. & Awada A. (20210111). On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors. : Molecular cancer therapeutics.

Chicago

Morschhauser Franck, Machiels Jean-Pascal, Salles Gilles, Rottey Sylvie, Rule Simon A J, Cunningham David, Peyrade Frederic, Fruchart Christophe, Arkenau Hendrik-Tobias, Genvresse Isabelle, Liu Li, Köchert Karl, Shen Kui, Kneip Christoph, Peña Carol E, Grevel Joachim, Zhang Jun, Cisternas Galia, Reschke Susanne, Granvil Camille and Awada Ahmad. 20210111. On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors. : Molecular cancer therapeutics.

Harvard

Morschhauser F., Machiels J., Salles G., Rottey S., Rule S. A. J., Cunningham D., Peyrade F., Fruchart C., Arkenau H., Genvresse I., Liu L., Köchert K., Shen K., Kneip C., Peña C. E., Grevel J., Zhang J., Cisternas G., Reschke S., Granvil C. and Awada A. (20210111). On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors. : Molecular cancer therapeutics.

MLA

Morschhauser Franck, Machiels Jean-Pascal, Salles Gilles, Rottey Sylvie, Rule Simon A J, Cunningham David, Peyrade Frederic, Fruchart Christophe, Arkenau Hendrik-Tobias, Genvresse Isabelle, Liu Li, Köchert Karl, Shen Kui, Kneip Christoph, Peña Carol E, Grevel Joachim, Zhang Jun, Cisternas Galia, Reschke Susanne, Granvil Camille and Awada Ahmad. On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors. : Molecular cancer therapeutics. 20210111.